These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 19877054

  • 1. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome.
    Pijpe J, Meijer JM, Bootsma H, van der Wal JE, Spijkervet FK, Kallenberg CG, Vissink A, Ihrler S.
    Arthritis Rheum; 2009 Nov; 60(11):3251-6. PubMed ID: 19877054
    [Abstract] [Full Text] [Related]

  • 2. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H.
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [Abstract] [Full Text] [Related]

  • 3. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma.
    Pijpe J, van Imhoff GW, Vissink A, van der Wal JE, Kluin PM, Spijkervet FK, Kallenberg CG, Bootsma H.
    Ann Rheum Dis; 2005 Jun; 64(6):958-60. PubMed ID: 15576414
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
    Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H.
    Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
    Delli K, Haacke EA, Kroese FG, Pollard RP, Ihrler S, van der Vegt B, Vissink A, Bootsma H, Spijkervet FK.
    Ann Rheum Dis; 2016 Nov; 75(11):1933-1938. PubMed ID: 26757748
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot study.
    Adler S, Körner M, Förger F, Huscher D, Caversaccio MD, Villiger PM.
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1862-8. PubMed ID: 23740889
    [Abstract] [Full Text] [Related]

  • 9. Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab.
    Devauchelle-Pensec V, Cagnard N, Pers JO, Youinou P, Saraux A, Chiocchia G.
    Arthritis Rheum; 2010 Aug; 62(8):2262-71. PubMed ID: 20506202
    [Abstract] [Full Text] [Related]

  • 10. A prospective study comparing incisional labial to incisional parotid biopsies in the detection and confirmation of sarcoidosis, Sjögren's disease, sialosis and lymphoma.
    Marx RE, Hartman KS, Rethman KV.
    J Rheumatol; 1988 Apr; 15(4):621-9. PubMed ID: 3397971
    [Abstract] [Full Text] [Related]

  • 11. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
    Vissink A, Kalk WW, Mansour K, Spijkervet FK, Bootsma H, Roodenburg JL, Kallenberg CG, Nieuw Amerongen AV.
    Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
    [Abstract] [Full Text] [Related]

  • 12. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).
    Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puéchal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J.
    Arthritis Rheum; 2004 Apr; 50(4):1270-6. PubMed ID: 15077311
    [Abstract] [Full Text] [Related]

  • 13. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
    Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K.
    Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis and cell proliferation: the paradox of salivary glands in Sjögren's disease.
    Herrera-Esparza R, Bollain-y-Goytia J, Ruvalcaba C, Ruvalcaba M, Pacheco-Tovar D, Avalos-Díaz E.
    Acta Reumatol Port; 2008 Jul; 33(3):299-303. PubMed ID: 18846009
    [Abstract] [Full Text] [Related]

  • 15. Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndrome.
    Steinfeld SD, Appelboom T, Delporte C.
    Arthritis Rheum; 2002 Aug; 46(8):2249-51. PubMed ID: 12209534
    [No Abstract] [Full Text] [Related]

  • 16. Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study.
    Zandbelt MM, de Wilde P, van Damme P, Hoyng CB, van de Putte L, van den Hoogen F.
    J Rheumatol; 2004 Jan; 31(1):96-101. PubMed ID: 14705226
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Salivary gland biopsy for Sjögren's syndrome.
    Delli K, Vissink A, Spijkervet FK.
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):23-33. PubMed ID: 24287191
    [Abstract] [Full Text] [Related]

  • 19. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
    Daridon C, Pers JO, Devauchelle V, Martins-Carvalho C, Hutin P, Pennec YL, Saraux A, Youinou P.
    Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
    [Abstract] [Full Text] [Related]

  • 20. Salivary histopathology in diagnosis of Sjögren's syndrome.
    Daniels TE.
    Scand J Rheumatol Suppl; 1986 Jul; 61():36-43. PubMed ID: 3296156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.